These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11443877)

  • 1. Intrabodies as antiviral agents.
    Marasco WA
    Curr Top Microbiol Immunol; 2001; 260():247-70. PubMed ID: 11443877
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracellular antibodies as a new class of therapeutic molecules for gene therapy.
    Chen SY; Bagley J; Marasco WA
    Hum Gene Ther; 1994 May; 5(5):595-601. PubMed ID: 7914435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-bodies as antiviral agents.
    Bitton N; Debre P; Eshhar Z; Gorochov G
    Curr Top Microbiol Immunol; 2001; 260():271-300. PubMed ID: 11443878
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases.
    Rondon IJ; Marasco WA
    Annu Rev Microbiol; 1997; 51():257-83. PubMed ID: 9343351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrabodies to human immunodeficiency virus type 1.
    Paillard F
    Hum Gene Ther; 1999 Jun; 10(9):1425-7. PubMed ID: 10395367
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
    Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
    Barouch DH; Santra S; Schmitz JE; Kuroda MJ; Fu TM; Wagner W; Bilska M; Craiu A; Zheng XX; Krivulka GR; Beaudry K; Lifton MA; Nickerson CE; Trigona WL; Punt K; Freed DC; Guan L; Dubey S; Casimiro D; Simon A; Davies ME; Chastain M; Strom TB; Gelman RS; Montefiori DC; Lewis MG; Emini EA; Shiver JW; Letvin NL
    Science; 2000 Oct; 290(5491):486-92. PubMed ID: 11039923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV-infection.
    Arya SK; Gallo RC
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4486-91. PubMed ID: 8633095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of HIV vectors for anti-HIV gene therapy.
    Poeschla E; Corbeau P; Wong-Staal F
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11395-9. PubMed ID: 8876146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in CCR5 regulation for HIV cure.
    Garg K; Khan AR; Taneja P
    Adv Protein Chem Struct Biol; 2021; 126():123-149. PubMed ID: 34090613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of the extracellular domains of C-C chemokine receptor 5 and the in vitro effects on simian immunodeficiency virus or HIV infectivity.
    Lehner T; Doyle C; Wang Y; Babaahmady K; Whittall T; Tao L; Bergmeier L; Kelly C
    J Immunol; 2001 Jun; 166(12):7446-55. PubMed ID: 11390497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS.
    Marasco WA; LaVecchio J; Winkler A
    J Immunol Methods; 1999 Dec; 231(1-2):223-38. PubMed ID: 10648940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing AIDS but not HIV-1 infection with a DNA vaccine.
    Shen X; Siliciano RF
    Science; 2000 Oct; 290(5491):463-5. PubMed ID: 11183769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo gene therapy for HIV-1 treatment.
    Scherer LJ; Rossi JJ
    Hum Mol Genet; 2011 Apr; 20(R1):R100-7. PubMed ID: 21505069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.
    Zaunders JJ; Kaufmann GR; Cunningham PH; Smith D; Grey P; Suzuki K; Carr A; Goh LE; Cooper DA
    J Infect Dis; 2001 Mar; 183(5):736-43. PubMed ID: 11181150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat.
    Poznansky MC; Foxall R; Mhashilkar A; Coker R; Jones S; Ramstedt U; Marasco W
    Hum Gene Ther; 1998 Mar; 9(4):487-96. PubMed ID: 9525310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons From HIV-1 Gene Therapy in Humanized Mice: Is Targeting Viral Entry the Road to Success?
    Petit N; Marodon G
    Curr Gene Ther; 2016; 16(1):56-64. PubMed ID: 26725877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
    Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for HIV.
    Lever AM
    Sex Transm Infect; 2001 Apr; 77(2):93-6. PubMed ID: 11287684
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy other than reverse transcriptase inhibitors for HIV infection.
    Kaplan JC; Hirsch MS
    Clin Lab Med; 1994 Jun; 14(2):367-91. PubMed ID: 7523020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.